PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
52.13
+0.40 (0.77%)
Jun 6, 2025, 4:00 PM - Market closed
PTC Therapeutics Analyst Ratings
Total Analysts
13
Consensus Rating
Buy
Price Target
$62.31
Upside
+19.53%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $68 → $74 | Buy | Maintains | $68 → $74 | +41.95% | May 27, 2025 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $55 → $68 | Hold → Strong Buy | Upgrades | $55 → $68 | +30.44% | May 9, 2025 |
| Barclays | Barclays | Hold Maintains $56 → $42 | Hold | Maintains | $56 → $42 | -19.43% | May 8, 2025 |
| Baird | Baird | Buy Maintains $70 → $66 | Buy | Maintains | $70 → $66 | +26.61% | May 7, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $57 → $58 | Buy | Maintains | $57 → $58 | +11.26% | May 7, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $113 → $112 | Buy | Maintains | $113 → $112 | +114.85% | May 7, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $75 → $67 | Buy | Maintains | $75 → $67 | +28.52% | May 7, 2025 |
| Citigroup | Citigroup | Strong Sell → Hold Upgrades $50 → $40 | Strong Sell → Hold | Upgrades | $50 → $40 | -23.27% | May 7, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $65 | Buy | Reiterates | $65 | +24.69% | Apr 22, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $78 → $75 | Buy | Maintains | $78 → $75 | +43.87% | Mar 31, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $72 → $78 | Buy | Maintains | $72 → $78 | +49.63% | Mar 14, 2025 |
| B of A Securities | B of A Securities | Sell → Hold Upgrades $41 → $55 | Sell → Hold | Upgrades | $41 → $55 | +5.51% | Mar 11, 2025 |
| Scotiabank | Scotiabank | Hold Initiates $55 | Hold | Initiates | $55 | +5.51% | Mar 7, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $67 → $70 | Buy | Initiates | $67 → $70 | +34.28% | Mar 7, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $74 → $72 | Buy | Maintains | $74 → $72 | +38.12% | Feb 28, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $60 → $63 | Buy | Maintains | $60 → $63 | +20.85% | Feb 18, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.